Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection, Parasite”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00120809
What this trial is testing

Intermittent Preventative Treatment With Sulfadoxine-Pyrimethamine in Gambian Multigravidae

Who this might be right for
Malaria
London School of Hygiene and Tropical Medicine 3,000
Post-approval studies (Phase 4)UnknownNCT03726593
What this trial is testing

Drug Combinations of Atovaquone-Proguanil (AP) With ACT

Who this might be right for
Plasmodium Falciparum Malaria (Drug Resistant)
Armed Forces Research Institute of Medical Sciences, Thailand 252
Early research (Phase 1)Study completedNCT00374998
What this trial is testing

Safety and Immunogenicity Study of the Malaria Vaccines FP9 PP and MVA PP

Who this might be right for
Malaria, FalciparumMalaria
European Vaccine Initiative 35
Very early researchStudy completedNCT00719602
What this trial is testing

Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAART

Who this might be right for
HIV InfectionsMalaria
International Maternal Pediatric Adolescent AIDS Clinical Trials Group 105
Large-scale testing (Phase 3)Study completedNCT03014167
What this trial is testing

Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)

Who this might be right for
HelminthiasisFilariasis
University of Washington 357,716
Post-approval studies (Phase 4)Looking for participantsNCT07074444
What this trial is testing

Treatment of Clonorchiasis in Guangxi With Albendazole, Tribendimidine, and Praziquantel

Who this might be right for
Clonorchiasis
First Affiliated Hospital of Guangxi Medical University 318
Post-approval studies (Phase 4)WithdrawnNCT01903057
What this trial is testing

Safety Study of Combined Azithromycin, Ivermectin and Albendazole for Trachoma and Lymphatic Filariasis

Who this might be right for
TrachomaLymphatic Filariasis
Emory University
Early research (Phase 1)Study completedNCT00513669
What this trial is testing

Phase Ib Trial of Two Virosome Formulated Malaria Vaccine Components (PEV 301, PEV 302) in Tanzania

Who this might be right for
Falciparum Malaria
Swiss Tropical & Public Health Institute 50
Large-scale testing (Phase 3)Study completedNCT03238131
What this trial is testing

IVM Alone vs ALB + IVM Against Onchocerciasis

Who this might be right for
Onchocerciasis
University Hospitals Cleveland Medical Center 272
Large-scale testing (Phase 3)Active Not RecruitingNCT04827537
What this trial is testing

Anti-protozoal Effect of Steroid Hormone 20-hydroxyecdysone

Who this might be right for
Giardia Lamblia Infection
Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan 200
Testing effectiveness (Phase 2)Study completedNCT02909712
What this trial is testing

Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania

Who this might be right for
MalariaPregnancy MalariaCardiotoxicity+2 more
London School of Hygiene and Tropical Medicine 201
Large-scale testing (Phase 3)Study completedNCT00257530
What this trial is testing

Imiquimod Plus Antimony Immunochemotherapy for Cutaneous Leishmaniasis

Who this might be right for
Cutaneous Leishmaniasis
Drugs for Neglected Diseases 80
Post-approval studies (Phase 4)Study completedNCT02084602
What this trial is testing

Assessment of Artesunate/Mefloquine in the Peruvian Amazon

Who this might be right for
Malaria, Falciparum
Instituto Nacional de Salud. Peru 45
Testing effectiveness (Phase 2)Looking for participantsNCT06798402
What this trial is testing

Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium Stibogluconate

Who this might be right for
Cutaneous Leishmaniasis
Al-Mustafa University College 80
Not applicableLooking for participantsNCT07389057
What this trial is testing

Assessing the Feasibility of Combining Dihydroartemisinin Piperaquine and Primaquine for Malaria Mass Drug Administration in High Endemic Communities in the Eastern Region of Ghana

Who this might be right for
Malaria Asymptomatic ParasitaemiaMalaria FalciparumMalaria Infection+1 more
Noguchi Memorial Institute for Medical Research 9,000
Early research (Phase 1)Study completedNCT01988636
What this trial is testing

Study of Safety and Effectiveness of Intravenous Immunization With PfSPZ Vaccine in Healthy African Adults

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 296
Not applicableStudy completedNCT02793336
What this trial is testing

Early Life Cohort in Papua Indonesia (ELIPI Study)

Who this might be right for
Malaria
Menzies School of Health Research 500
Not applicableNot Yet RecruitingNCT07506967
What this trial is testing

Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers

Who this might be right for
Skin and Connective Tissue DiseasesNeglected Tropical DiseasesLeprosy+10 more
Kenya Medical Research Institute 2,420
Not applicableStudy completedNCT00314899
What this trial is testing

Fetal Immunity to Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 500
Large-scale testing (Phase 3)Study completedNCT02699099
What this trial is testing

Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

Who this might be right for
MalariaMalaria Vaccines
GlaxoSmithKline 699
Next Page